title: Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.
abstract: Codon bias deoptimization has been previously used to successfully attenuate human pathogens, including poliovirus, respiratory syncytial virus, and influenza virus. We have applied a similar technology to deoptimize the capsid-coding region (P1) of foot-and-mouth disease virus (FMDV). Despite the introduction of 489 nucleotide changes (19%), synonymous deoptimization of the P1 region rendered a viable FMDV progeny. The resulting strain was stable and reached cell culture titers similar to those obtained for wild-type (WT) virus, but at reduced specific infectivity. Studies in mice showed that 100% of animals inoculated with the FMDV A12 P1 deoptimized mutant (A12-P1 deopt) survived, even when the animals were infected at doses 100 times higher than the dose required to cause death by WT virus. All mice inoculated with the A12-P1 deopt mutant developed a strong antibody response and were protected against subsequent lethal challenge with WT virus at 21 days postinoculation. Remarkably, the vaccine safety margin was at least 1,000-fold higher for A12-P1 deopt than for WT virus. Similar patterns of attenuation were observed in swine, in which animals inoculated with A12-P1 deopt virus did not develop clinical disease until doses reached 1,000 to 10,000 times the dose required to cause severe disease in 2 days with WT A12. Consistently, high levels of antibody titers were induced, even at the lowest dose tested. These results highlight the potential use of synonymous codon pair deoptimization as a strategy to safely attenuate FMDV and further develop live attenuated vaccine candidates to control such a feared livestock disease.
  
  
  OBJECTIVE
  Foot-and-mouth disease (FMD) is one of the most feared viral diseases that can affect livestock. Although this disease appeared to be contained in developed nations by the end of the last century, recent outbreaks in Europe, Japan, Taiwan, South Korea, etc., have demonstrated that infection can spread rapidly, causing devastating economic and social consequences. The Global Foot-and-Mouth Disease Research Alliance (GFRA), an international organization launched in 2003, has set as part of their five main goals the development of next-generation control measures and strategies, including improved vaccines and biotherapeutics. Our work demonstrates that newly developed codon pair bias deoptimization technologies can be applied to FMD virus to obtain attenuated strains with potential for further development as novel live attenuated vaccine candidates that may rapidly control disease without reverting to virulence.
authors.affiliation: Plum Island Animal Disease Center, ARS, USDA, Greenport, New York, USA Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, Connecticut, USA.
authors.forename: Fayna
authors.initials: F
authors.lastname: Diaz-San Segundo
authors.affiliation: Plum Island Animal Disease Center, ARS, USDA, Greenport, New York, USA.
authors.forename: Gisselle N
authors.initials: GN
authors.lastname: Medina
authors.affiliation: Oak Ridge Institute for Science and Education-Plum Island Animal Disease Center Research Participation Program, Oak Ridge, Tennessee, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Ramirez-Medina
authors.affiliation: Oak Ridge Institute for Science and Education-Plum Island Animal Disease Center Research Participation Program, Oak Ridge, Tennessee, USA.
authors.forename: Lauro
authors.initials: L
authors.lastname: Velazquez-Salinas
authors.affiliation: Plum Island Animal Disease Center, ARS, USDA, Greenport, New York, USA.
authors.forename: Marla
authors.initials: M
authors.lastname: Koster
authors.affiliation: Plum Island Animal Disease Center, ARS, USDA, Greenport, New York, USA.
authors.forename: Marvin J
authors.initials: MJ
authors.lastname: Grubman
authors.affiliation: Plum Island Animal Disease Center, ARS, USDA, Greenport, New York, USA teresa.delossantos@ars.usda.gov.
authors.forename: Teresa
authors.initials: T
authors.lastname: de los Santos
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood*; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D029544:Foot-and-Mouth Disease Virus / Q000235:genetics / Q000254:growth & development* / Q000276:immunology*; D008810:Mice, Inbred C57BL; D000069456:Silent Mutation; D016019:Survival Analysis; D013552:Swine; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification*; D014774:Virulence
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines